The May 3 subway collapse in Mexico City highlights the ongoing institutional weakness and corruption of the current administration, with deadly results for the country’s citizens. Read more at the Baker Institute Blog.
Is Mexico's President López Obrador, a Trump fan, capable of making the changes needed for a new and different relationship with the U.S.? The authors examine López Obrador's early moves, which portend a difficult four years.
An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.
President López Obrador was skeptical of the coronavirus threat and ignored the recommendations of his own health experts. He downplayed the crisis and relied on his intuition instead of science, with disastrous results. He will be even more distracted in the coming months as he campaigns for re-election.
Even before the pandemic, Mexico’s health care system was in crisis, with shortages of medical supplies, drugs, and personnel. A president that is downplaying the outbreak, brandishing amulets to “protect” him from the virus, isn’t helping matters. Baker Institute blog: https://bit.ly/2w6KJHV
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.